Solas in May joined a $49 million financing for new drug developer Arrivo Bioventures LLC. Arrivo executives Steve Butts and Bill Wofford were former leaders of Aerial, Neuronex and Addrenex.
http://www.wsj.com/articles/drug-developer-arrivo-bioventures-launches-with-49m-1464197754
